Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hereditary cancer gene panel test reports: wide heterogeneity suggests need for standardization.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Nov 2018

Makhnoon Sukh, Shirts Brian H, Bowen Deborah J, Fullerton Stephanie M

Abstract excerpt

PURPOSE: Laboratory-generated genomic test reports are used to convey complex, and frequently multivariant or uncertain, information about disease risk to medical genetics professionals as well as to nonspecialist clinicians, patients, and family members. However, few guidelines exist to guide the content and format of genomic test reports, and little is known about variation in current reporting practices....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Exome Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Genome, Human

Share to Laboratories

Share to Neoplasm Proteins

Share to Neoplasms

Share to United States

Source

Identifiers

PMID: 29493582
DOI: 10.1038/gim.2018.23

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hereditary cancer gene panel test reports: wide heterogeneity suggests need for standardization.PMID 29493582Read ↗

Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels.Semantic proximity Read ↗

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.Semantic proximity Read ↗

Measuring the Meaning of Genomic Results: Harmonization of the Metric for Case-Level Results in the CSER2 ConsortiumSemantic proximity Read ↗

A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findingsSemantic proximity Read ↗

Evaluation of laboratory perspectives on hereditary cancer panels.Semantic proximity Read ↗

The landscape of reported VUS in multi-gene panel and genomic testing: Time for a changeSemantic proximity Read ↗

Pitfalls and challenges in genetic test interpretation: An exploration of genetic professionals experience with interpretation of resultsSemantic proximity Read ↗

Reporting practices for variants of uncertain significance from next generation sequencing technologies.Semantic proximity Read ↗

Consistency of variant interpretations among bioinformaticians and clinical geneticists in hereditary cancer panels.Semantic proximity Read ↗

Imprecision medicine: Systematic gaps in reporting variants of uncertain significance (VUS) and their reclassifications.Semantic proximity Read ↗

Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratoriesSemantic proximity Read ↗

The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.